Search

Jennifer A Rivard

Examiner (ID: 3971, Phone: (571)272-2609 , Office: P/2911 )

Most Active Art Unit
2911
Art Unit(s)
2901, 2911, 2900
Total Applications
6935
Issued Applications
6877
Pending Applications
7
Abandoned Applications
50

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18939677 [patent_doc_number] => 20240034816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERING [patent_app_type] => utility [patent_app_number] => 18/469947 [patent_app_country] => US [patent_app_date] => 2023-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18469947 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/469947
NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERING Sep 18, 2023 Pending
Array ( [id] => 18725875 [patent_doc_number] => 20230340105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => NOVEL ANTIGEN BINDING MOLECULE FORMATS [patent_app_type] => utility [patent_app_number] => 18/318871 [patent_app_country] => US [patent_app_date] => 2023-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318871 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/318871
NOVEL ANTIGEN BINDING MOLECULE FORMATS May 16, 2023 Pending
Array ( [id] => 18725874 [patent_doc_number] => 20230340104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 18/308338 [patent_app_country] => US [patent_app_date] => 2023-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 135551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308338 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/308338
IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS Apr 26, 2023 Pending
Array ( [id] => 18537555 [patent_doc_number] => 20230242653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => AGONISTIC ANTI-IL-2R ANTIBODIES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/164442 [patent_app_country] => US [patent_app_date] => 2023-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67911 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164442 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/164442
Agonistic anti-IL-2R antibodies and methods of use Feb 2, 2023 Issued
Array ( [id] => 18420171 [patent_doc_number] => 20230174632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => COMBINATIONS FOR ALLERGY THERAPY [patent_app_type] => utility [patent_app_number] => 17/980397 [patent_app_country] => US [patent_app_date] => 2022-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17980397 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/980397
COMBINATIONS FOR ALLERGY THERAPY Nov 2, 2022 Pending
Array ( [id] => 18391416 [patent_doc_number] => 20230159634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR [patent_app_type] => utility [patent_app_number] => 17/877432 [patent_app_country] => US [patent_app_date] => 2022-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877432 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/877432
ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR Jul 28, 2022 Pending
Array ( [id] => 18294260 [patent_doc_number] => 20230103946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => THERAPEUTIC INTERFERON ALPHA 1 PROTEINS [patent_app_type] => utility [patent_app_number] => 17/813985 [patent_app_country] => US [patent_app_date] => 2022-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813985 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813985
THERAPEUTIC INTERFERON ALPHA 1 PROTEINS Jul 20, 2022 Pending
Array ( [id] => 18036258 [patent_doc_number] => 20220380473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => ANTI-GAL3 ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/813578 [patent_app_country] => US [patent_app_date] => 2022-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813578 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813578
ANTI-GAL3 ANTIBODIES AND USES THEREOF Jul 18, 2022 Pending
Array ( [id] => 17982605 [patent_doc_number] => 20220348641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => PROCESS FOR OBTAINING ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/858112 [patent_app_country] => US [patent_app_date] => 2022-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858112 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/858112
PROCESS FOR OBTAINING ANTIBODIES Jul 5, 2022 Pending
Array ( [id] => 18065535 [patent_doc_number] => 20220396622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => FC VARIANTS WITH REDUCED EFFECTOR FUNCTION [patent_app_type] => utility [patent_app_number] => 17/848808 [patent_app_country] => US [patent_app_date] => 2022-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/848808
FC VARIANTS WITH REDUCED EFFECTOR FUNCTION Jun 23, 2022 Pending
Array ( [id] => 18980169 [patent_doc_number] => 11905329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Anti-PD-1 antibodies and uses thereof [patent_app_type] => utility [patent_app_number] => 17/834237 [patent_app_country] => US [patent_app_date] => 2022-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 45420 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834237 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/834237
Anti-PD-1 antibodies and uses thereof Jun 6, 2022 Issued
Array ( [id] => 18519279 [patent_doc_number] => 11709167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use [patent_app_type] => utility [patent_app_number] => 17/826108 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 29656 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826108 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/826108
Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use May 25, 2022 Issued
Array ( [id] => 17865461 [patent_doc_number] => 20220288196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => METHODS OF ORAL IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/752639 [patent_app_country] => US [patent_app_date] => 2022-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40628 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752639 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/752639
METHODS OF ORAL IMMUNOTHERAPY May 23, 2022 Pending
Array ( [id] => 18468858 [patent_doc_number] => 20230203141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHODS OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/736859 [patent_app_country] => US [patent_app_date] => 2022-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/736859
METHODS OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES May 3, 2022 Pending
Array ( [id] => 18020618 [patent_doc_number] => 20220372117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => ANTI-ALLERGEN ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/714507 [patent_app_country] => US [patent_app_date] => 2022-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714507 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/714507
ANTI-ALLERGEN ANTIBODIES Apr 5, 2022 Pending
Array ( [id] => 18732566 [patent_doc_number] => 11801286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use [patent_app_type] => utility [patent_app_number] => 17/707243 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 12596 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707243 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/707243
Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use Mar 28, 2022 Issued
Array ( [id] => 17719123 [patent_doc_number] => 20220211842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => Methods and Devices for the Treatment of Food Allergies [patent_app_type] => utility [patent_app_number] => 17/697467 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16960 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -164 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697467
Methods and Devices for the Treatment of Food Allergies Mar 16, 2022 Pending
Array ( [id] => 17850596 [patent_doc_number] => 20220280637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/672571 [patent_app_country] => US [patent_app_date] => 2022-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19776 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672571 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/672571
NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF Feb 14, 2022 Pending
Array ( [id] => 18518526 [patent_doc_number] => 11708407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Antigen binding molecule formats [patent_app_type] => utility [patent_app_number] => 17/666116 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 48 [patent_no_of_words] => 45802 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17666116 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/666116
Antigen binding molecule formats Feb 6, 2022 Issued
Array ( [id] => 17958664 [patent_doc_number] => 20220339244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => METHODS OF TREATING KAWASAKI DISEASE [patent_app_type] => utility [patent_app_number] => 17/648242 [patent_app_country] => US [patent_app_date] => 2022-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17648242 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/648242
METHODS OF TREATING KAWASAKI DISEASE Jan 17, 2022 Pending
Menu